The Jenner Vaccine Foundation
The Foundation seeks to enhance philanthropic support of vaccinology and is currently evaluating options for enhanced fundraising activities. The Foundation currently supports vaccine research and development through the Jenner Institute. The Foundation Board appoints the Director of the Institute, elects Jenner Investigators (currently numbering 24) and has funded space and facilities for vaccine research and development.
The Foundation actively supports enhanced collaborative interactions between researchers at The Pirbright Institute working on veterinary vaccines and those at Oxford University developing new vaccines for human use. The Foundation has also provided support for scientists from the former Edward Jenner Institute for Vaccine Research to continue their work as part of the Jenner Institute. The Foundation draws Trustees from both Oxford University and the Pirbright Institute and has an external chair and three further independent trustees.
David Salisbury CB (Chairman), Director of Immunisation, UK Department of Health
Norman Begg, VP and Chief Medical Officer, GSK Biologicals
John Fazakerley, Director, The Pirbright Institute
Paul Fine, Professor of Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine
Sir Andrew McMichael FRS, Director of the Weatherall Institute of Molecular Medicine, University of Oxford
David Paton, Director of Science, The Pirbright Institute
Andrew Pollard, Professor of Paediatrics, University of Oxford
Ian Tarpey, Head Global Poultry / Discovery & Technology, MSD Animal Health, Netherlands